A modular cell-culture platform demonstrates accelerated process development.
Harald Bradl
Advertisement
Harald Bradl is director, cell culture development at Boehringer Ingelheim Pharma GmbH & Co. KG.
Articles by Harald Bradl
Advertisement
Latest Updated Articles
Platform Approach Speeds Process DevelopmentPublished: April 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
RNAnalytics’ Viktoria Enkmann Ponders Nanoparticle Characterization Advances at CPHI Frankfurt: Part One
5
